{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:35:20Z","timestamp":1768552520648,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["T32 EB021962"],"award-info":[{"award-number":["T32 EB021962"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]},{"name":"National Institutes of Health, United States","award":["P01AI165077"],"award-info":[{"award-number":["P01AI165077"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01333-4","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:54:06Z","timestamp":1765551246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins"],"prefix":"10.1038","volume":"11","author":[{"given":"Peter J.","family":"Halfmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Carneal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi S.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1333_CR1","unstructured":"WHO Number of COVID-19 Deaths Reported to WHO. https:\/\/data.who.int\/dashboards\/covid19\/deaths (2023)."},{"key":"1333_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. -f, Xu, W. & Liu, S. -w Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"1333_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637651","volume":"12","author":"P Shah","year":"2021","unstructured":"Shah, P., Canziani, G. A., Carter, E. P. & Chaiken, I. The case for S2: the potential benefits of the S2 subunit of the SARS-CoV-2 spike protein as an immunogen in fighting the COVID-19 pandemic. Front Immunol. 12, 637651 (2021).","journal-title":"Front Immunol."},{"key":"1333_CR4","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1016\/j.cell.2021.06.005","volume":"184","author":"F Amanat","year":"2021","unstructured":"Amanat, F. et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 184, 3936\u20133948.e3910 (2021).","journal-title":"Cell"},{"key":"1333_CR5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","volume":"386","author":"SA Madhi","year":"2022","unstructured":"Madhi, S. A. et al. Population immunity and covid-19 severity with omicron variant in South Africa. N. Engl. J. Med. 386, 1314\u20131326 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1333_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2023.03.001","volume":"70","author":"L Wang","year":"2023","unstructured":"Wang, L., M\u00f8hlenberg, M., Wang, P. & Zhou, H. Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron. Cytokine Growth Factor Rev. 70, 13\u201325 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1333_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51973-8","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants. Nat. Commun. 15, 7715 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105649","volume":"25","author":"M Brinkkemper","year":"2022","unstructured":"Brinkkemper, M. et al. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses. iScience 25, 105649 (2022).","journal-title":"iScience"},{"key":"1333_CR9","doi-asserted-by":"publisher","unstructured":"Halfmann, P. J. et al. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nat. Commun. 15, https:\/\/doi.org\/10.1038\/s41467-024-45495-6 (2024).","DOI":"10.1038\/s41467-024-45495-6"},{"key":"1333_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science 377, eabq0839 (2022).","journal-title":"Science"},{"key":"1333_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","journal-title":"Science"},{"key":"1333_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208425120","volume":"120","author":"DB Lee","year":"2023","unstructured":"Lee, D. B. et al. Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge. Proc. Natl. Acad. Sci. 120, e2208425120 (2023).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1333_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104341","volume":"86","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses. EBioMedicine 86, 104341 (2022).","journal-title":"EBioMedicine"},{"key":"1333_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn3715","volume":"14","author":"KW Ng","year":"2022","unstructured":"Ng, K. W. et al. SARS-CoV-2 S2\u2013targeted vaccination elicits broadly neutralizing antibodies. Sci. Transl. Med. 14, eabn3715 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1333_CR15","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41422-022-00746-3","volume":"32","author":"W Pang","year":"2022","unstructured":"Pang, W. et al. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein. Cell Res. 32, 1068\u20131085 (2022).","journal-title":"Cell Res."},{"key":"1333_CR16","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.apsb.2023.05.030","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration. Acta Pharm. Sin. B 13, 3339\u20133351 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"1333_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43638-9","volume":"14","author":"AB Kapingidza","year":"2023","unstructured":"Kapingidza, A. B. et al. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes. Nat. Commun. 14, 7897 (2023).","journal-title":"Nat. Commun."},{"key":"1333_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45404-x","volume":"15","author":"C-L Hsieh","year":"2024","unstructured":"Hsieh, C.-L. et al. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge. Nat. Commun. 15, 1553 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49656-5","volume":"15","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines. Nat. Commun. 15, 5496 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55824-y","volume":"16","author":"PJ Halfmann","year":"2025","unstructured":"Halfmann, P. J. et al. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice. Nat. Commun. 16, 462 (2025).","journal-title":"Nat. Commun."},{"key":"1333_CR21","doi-asserted-by":"publisher","first-page":"e02566","DOI":"10.1128\/mbio.02566-22","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. ACE2-independent bat sarbecovirus entry and replication in human and bat cells. mBio 13, e02566\u201302522 (2022).","journal-title":"mBio"},{"key":"1333_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol 5, 562\u2013569 (2020).","journal-title":"Nat. Microbiol"},{"key":"1333_CR23","doi-asserted-by":"publisher","first-page":"e1010828","DOI":"10.1371\/journal.ppat.1010828","volume":"18","author":"SN Seifert","year":"2022","unstructured":"Seifert, S. N. et al. An ACE2-dependent sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. PLoS Pathog. 18, e1010828 (2022).","journal-title":"PLoS Pathog."},{"key":"1333_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/MS9.0000000000000486","volume":"85","author":"RK Mohapatra","year":"2023","unstructured":"Mohapatra, R. K., Mishra, S., Rabaan, A. A., Mohanty, A. & Sah, R. Human-transmissible sarbecovirus \u2018Khosta-2\u2019 similar to SARS-CoV-2: Potential global threat?. Ann. Med. Surg. 85, 1327\u20131328 (2023).","journal-title":"Ann. Med. Surg."},{"key":"1333_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veab007","volume":"7","author":"HL Wells","year":"2021","unstructured":"Wells, H. L. et al. The evolutionary history of ACE2 usage within the coronavirus subgenus sarbecovirus. Virus Evol. 7, veab007 (2021).","journal-title":"Virus Evol."},{"key":"1333_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41586-022-04464-z","volume":"603","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Nature 603, 913\u2013918 (2022).","journal-title":"Nature"},{"key":"1333_CR27","doi-asserted-by":"publisher","unstructured":"Lee, J. et al. Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus. Cell Host Microbe 31, https:\/\/doi.org\/10.1101\/2023.09.12.557371 (2023).","DOI":"10.1101\/2023.09.12.557371"},{"key":"1333_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202002140","volume":"10","author":"A Castro","year":"2021","unstructured":"Castro, A., Carre\u00f1o, J. M., Duehr, J., Krammer, F. & Kane, R. S. Refocusing the immune response to selected epitopes on a zika virus protein antigen by nanopatterning. Adv. Healthc. Mater. 10, 2002140 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"1333_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202729","volume":"12","author":"SJ Frey","year":"2023","unstructured":"Frey, S. J. et al. Nanovaccines displaying the influenza virus hemagglutinin in an inverted orientation elicit an enhanced stalk-directed antibody response. Adv. Healthc. Mater. 12, 2202729 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"1333_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s42003-021-02128-8","volume":"4","author":"S Chiba","year":"2021","unstructured":"Chiba, S. et al. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Commun. Biol. 4, 597 (2021).","journal-title":"Commun. Biol."},{"key":"1333_CR31","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1074\/jbc.M311791200","volume":"279","author":"K Papanikolopoulou","year":"2004","unstructured":"Papanikolopoulou, K., Forge, V., Goeltz, P. & Mitraki, A. Formation of highly stable chimeric trimers by fusion of an adenovirus fiber shaft fragment with the foldon domain of bacteriophage T4 Fibritin*. J. Biol. Chem. 279, 8991\u20138998 (2004).","journal-title":"J. Biol. Chem."},{"key":"1333_CR32","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"1333_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4428","volume":"31","author":"DF Thieker","year":"2022","unstructured":"Thieker, D. F. et al. Stabilizing proteins, simplified: a Rosetta-based webtool for predicting favorable mutations. Protein Sci. 31, e4428 (2022).","journal-title":"Protein Sci."},{"key":"1333_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.abj3321","volume":"373","author":"D Pinto","year":"2021","unstructured":"Pinto, D. et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science 373, 1109\u20131116 (2021).","journal-title":"Science"},{"key":"1333_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83710","volume":"12","author":"RP Silva","year":"2023","unstructured":"Silva, R. P. et al. Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses. eLife 12, e83710 (2023).","journal-title":"eLife"},{"key":"1333_CR36","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1073\/pnas.1517719113","volume":"113","author":"VD Menachery","year":"2016","unstructured":"Menachery, V. D. et al. SARS-like WIV1-CoV poised for human emergence. Proc. Natl. Acad. Sci. 113, 3048\u20133053 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1333_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"1333_CR38","doi-asserted-by":"publisher","unstructured":"Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv, 2021.2010.2004.463034 https:\/\/doi.org\/10.1101\/2021.10.04.463034 (2022).","DOI":"10.1101\/2021.10.04.463034"},{"key":"1333_CR39","first-page":"D570","volume":"48","author":"AL Mitchell","year":"2019","unstructured":"Mitchell, A. L. et al. MGnify: the microbiome analysis resource in 2020. Nucleic Acids Res. 48, D570\u2013D578 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1333_CR40","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/bioinformatics\/btm098","volume":"23","author":"BE Suzek","year":"2007","unstructured":"Suzek, B. E., Huang, H., McGarvey, P., Mazumder, R. & Wu, C. H. UniRef: comprehensive and non-redundant UniProt reference clusters. Bioinformatics 23, 1282\u20131288 (2007).","journal-title":"Bioinformatics"},{"key":"1333_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","volume":"17","author":"JK Leman","year":"2020","unstructured":"Leman, J. K. et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks. Nat. Methods 17, 665\u2013680 (2020).","journal-title":"Nat. Methods"},{"key":"1333_CR42","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1021\/acs.jctc.6b00819","volume":"12","author":"H Park","year":"2016","unstructured":"Park, H. et al. Simultaneous optimization of biomolecular energy functions on features from small molecules and macromolecules. J. Chem. Theory Comput. 12, 6201\u20136212 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"1333_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jmb.2013.09.016","volume":"426","author":"M Fairhead","year":"2014","unstructured":"Fairhead, M., Krndija, D., Lowe, E. D. & Howarth, M. Plug-and-play pairing via defined divalent streptavidins. J. Mol. Biol. 426, 199\u2013214 (2014).","journal-title":"J. Mol. Biol."},{"key":"1333_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nprot.2008.20","volume":"3","author":"M Howarth","year":"2008","unstructured":"Howarth, M. & Ting, A. Y. Imaging proteins in live mammalian cells with biotin ligase and monovalent streptavidin. Nat. Protoc. 3, 534\u2013545 (2008).","journal-title":"Nat. Protoc."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01333-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:17:30Z","timestamp":1768486650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01333-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01333-4","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}